期刊
PHARMACOGENOMICS JOURNAL
卷 9, 期 4, 页码 283-290出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/tpj.2009.10
关键词
CYP2C8; CYP2C9; paclitaxel; population genetics; haplotypes; evolution
资金
- NIH [AA009379, GM57672]
We have studied the global frequency distributions of 10 single nucleotide polymorphisms (SNPs) across 132 kb of CYP2C8 and CYP2C9 in similar to 2500 individuals representing 45 populations. Five of the SNPs were in noncoding sequences; the other five involved the more common missense variants (four in CYP2C8, one in CYP2C9) that change amino acids in the gene products. One haplotype containing two CYP2C8 coding variants and one CYP2C9 coding variant reaches an average frequency of 10% in Europe; a set of haplotypes with a different CYP2C8 coding variant reaches 17% in Africa. In both cases these haplotypes are found in other regions of the world at < 1%. This considerable geographic variation in haplotype frequencies impacts the interpretation of CYP2C8/CYP2C9 association studies, and has pharmacogenomic implications for drug interactions. The Pharmacogenomics Journal (2009) 9, 283-290; doi: 10.1038/tpj.2009.10; published online 21 April 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据